BioMed Research International / 2015 / Article / Tab 4

Research Article

Is Lipoprotein-Associated Phospholipase A2 a Link between Inflammation and Subclinical Atherosclerosis in Rheumatoid Arthritis?

Table 4

Results of simple regression models among 71 patients with early RA with the concentration of Lp-PLA2 at T5 as the dependent variable.

Lp-PLA2 at T5
β95% CI value

IMT T5 (n = 66)4.4/mm−2.7; 11.50.22
FMD T5 (n = 66)−1.7/%−3.8; 0.40.10
Non-HDL-cholesterol T5 (n = 61)19.0/mmolL−110.5; 27.50.001
HDL T5 (n = 61)−31.8/mmolL−1−50.3; −13.30.001
Cholesterol T5 (n = 61)11.5/mmolL−12.1; 20.80.02
Ever smoking (n = 66)0.4/year−0.3; 1.10.26
BMI T5 (n = 66)2.5/unit0.3; 4.70.03
SCORE T5 (n = 61)3.6/unit−2.0; 9.20.21
Reynolds Risk Score T5 (n = 39)2.8/unit−0.2; 5.70.06

RA: rheumatoid arthritis; Lp-PLA2: lipoprotein-associated phospholipase A2; IMT: intima media thickness; FMD: flow mediated dilation; HDL: high-density lipoproteins; BMI: body mass index.